Literature DB >> 313159

Pneumocystis pneumonia. Animal model: pneumocystis cartinii pneumonia in the immunosuppressed rat.

F W Chandler, J K Frenkel, W G Campbell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 313159      PMCID： PMC2042340     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN： 0002-9440            Impact factor:   4.307


× No keyword cloud information.
  11 in total

1.  Ultrastructure of Pneumocystis in human lung. Life cycle in human pneumocystosis.

Authors:  W G Campbell
Journal:  Arch Pathol       Date:  1972-04

2.  Activation and transmission in rats of infection with Pneumocystis.

Authors:  J O Hendley; T H Weller
Journal:  Proc Soc Exp Biol Med       Date:  1971-09

3.  Pneumocystis carinii in lungs of rats treated with cortisone acetate. Ultrastructural observations relating to the life cycle.

Authors:  E G Barton; W G Campbell
Journal:  Am J Pathol       Date:  1969-02       Impact factor: 4.307

4.  Propagation of Pneumocystis carinii in vitro.

Authors:  L L Pifer; W T Hughes; M J Murphy
Journal:  Pediatr Res       Date:  1977-04       Impact factor: 3.756

5.  Serial propagation of Pneumocystis carinii in cell line cultures.

Authors:  C R Latorre; A J Sulzer; L G Norman
Journal:  Appl Environ Microbiol       Date:  1977-05       Impact factor: 4.792

6.  Protein-calorie malnutrition. A host determinant for Pneumocystis carinii infection.

Authors:  W T Hughes; R A Price; F Sisko; W S Havron; A G Kafatos; M Schonland; P M Smythe
Journal:  Am J Dis Child       Date:  1974-07

7.  Pulmonary pneumocystosis in nonhuman primates.

Authors:  F W Chandler; H M McClure; W G Campbell; J C Watts
Journal:  Arch Pathol Lab Med       Date:  1976-03       Impact factor: 5.534

Review 8.  Pneumocystis carinii as the cause of human disease: historical perspective and magnitude of the problem: introductory remarks.

Authors:  D C Gajdusek
Journal:  Natl Cancer Inst Monogr       Date:  1976-10

9.  Efficacy of trimethoprim and sulfamethoxazole in the prevention and treatment of Pneumocystis carinii pneumonitis.

Authors:  W T Hughes; P C McNabb; T D Makres; S Feldman
Journal:  Antimicrob Agents Chemother       Date:  1974-03       Impact factor: 5.191

10.  The interaction in vitro of Pneumocystis carinii with macrophages and L-cells.

Authors:  H Masur; T C Jones
Journal:  J Exp Med       Date:  1978-01-01       Impact factor: 14.307
View more
  6 in total

Review 1.  Genetics of surface antigen expression in Pneumocystis carinii.

Authors:  J R Stringer; S P Keely
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

2.  Latent Pneumocystis carinii infection in commercial rat colonies: comparison of inductive immunosuppressants plus histopathology, PCR, and serology as detection methods.

Authors:  S H Weisbroth; J Geistfeld; S P Weisbroth; B Williams; S H Feldman; M J Linke; S Orr; M T Cushion
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

Review 3.  Pathological and protective immunity to Pneumocystis infection.

Authors:  Taylor Eddens; Jay K Kolls
Journal:  Semin Immunopathol       Date:  2014-11-25       Impact factor: 9.623

4.  Effect of surfactant replacement on Pneumocystis carinii pneumonia in rats.

Authors:  E P Eijking; G J van Daal; R Tenbrinck; A Luijendijk; J F Sluiters; E Hannappel; B Lachmann
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

5.  Diversity at the locus associated with transcription of a variable surface antigen of Pneumocystis carinii as an index of population structure and dynamics in infected rats.

Authors:  Scott P Keely; Melanie T Cushion; James R Stringer
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

6.  Phospholipase activities of bronchoalveolar lavage fluid in rat Pneumocystis carinii pneumonia.

Authors:  S Kernbaum; J Masliah; L G Alcindor; C Bouton; D Christol
Journal:  Br J Exp Pathol       Date:  1983-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.